Skip to main navigation Skip to search Skip to main content

Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

12 Downloads (Pure)
Original languageEnglish
Pages (from-to)5-7
Number of pages3
JournalEuropean Neuropsychopharmacology
Volume85
DOIs
Publication statusPublished - Aug 2024

Bibliographical note

© 2024 Elsevier B.V. and ECNP.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this